Robocath is a medical robotics start-up company.
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions.R-One™ is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs.Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 16, 2021 | Debt Financing | €15M | 1 | European Investment Bank | — | Detail |
Apr 29, 2020 | Series C | €40M | 1 | — | — | Detail |
Sep 3, 2019 | Series Unknown | €5M | 1 | — | — | Detail |
Dec 7, 2017 | Series Unknown | €1.70M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Investment Bank | Yes | Debt Financing |
CS Group | — | Series C |
Crédit Agricole Normandie | — | Series Unknown |
Crédit Agricole Innovations et Territoires (CAIT) | — | Series Unknown |